Back
Illumina, Inc. (ILMN)
Life Sciences Tools & ServicesILMN · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$225.01
+0.76%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$5.45
ROE
33.8%
Gross margin
68.3%
Debt/Equity
0.95x
Revenue growth
4.8%
Illumina, Inc. — company intelligence
Earnings surprises
Q2 2026$1.31 vs $1.25 est+4.7%
Q1 2026$1.15 vs $1.08 est+6.9%
Q4 2025$1.15 vs $1.08 est+6.9%
Q3 2025$1.34 vs $1.19 est+12.7%
Analyst consensus · 28 analysts
17 Buy8 Hold3 Sell
Updated Aug 20, 2026
Insider activity · 90 days
3 buys44 sellsnet -1,414,152 shares
Meister Keith A.Sell 118,753 · Aug 5, 2026
Meister Keith A.Sell 68,047 · Aug 5, 2026
Meister Keith A.Sell 2,450 · Aug 5, 2026
Recent SEC filings
8-K — Material event reportAug 13, 2026
8-K — Material event reportAug 12, 2026
4 — Insider transaction reportAug 7, 2026
Latest news
Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On Wednesday — Benzinga · 5d ago
What Makes Illumina (ILMN) a New Strong Buy Stock — Yahoo · 2w ago
Caris Life Sciences: Guidance Raised, Valuation Still Attractive — SeekingAlpha · 2w ago
Standard BioTools Reports Second Quarter 2026 Financial Results — Yahoo · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.